Results 81 to 90 of about 4,446,831 (170)
Ototoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions. Objective: Pure tone audiometry (PTA) is currently widely used to monitor ototoxicity, but this method is timeconsuming.
M. K. Md Daud +3 more
doaj +2 more sources
Hearing Loss in Adults With Diabetes and Prediabetes: A Systematic Review and Meta‐Analysis
ABSTRACT Diabetes impairs hearing through microvascular damage and neuropathy, yet the prevalence of moderate‐to‐severe hearing loss (≥ 40 dB HL) remains inadequately explored. Variations by age, diabetes duration, and socioeconomic factors are inadequately characterised. This systematic review quantified the prevalence and comparative risk of moderate‐
Mehwish Nisar +4 more
wiley +1 more source
Highly active antiretroviral therapy: Does it Sound toxic?
Objective : The main objective of the current study is to monitor the auditory status in a group of adults with AIDS, receiving Highly Active Antiretroviral Therapy (HAART) (3TC -lamivudine, D4T - stavudine, and efavirenz) in a hospital outpatient clinic
Katijah Khoza-Shangase
doaj +1 more source
Intravesical therapy for recurrent urinary tract infection: a systematic review and meta‐analysis
Objective To undertake a systematic review and meta‐analysis to evaluate the efficacy, safety, and clinical applicability of intravesical instillations for preventing recurrent urinary tract infections (rUTIs). Methods PubMed/MEDLINE, Embase, Cochrane CENTRAL, Scopus, and Web of Science were searched from January 2000 to April 2025 for randomised and ...
Matthew Kwon +3 more
wiley +1 more source
Evaluation of insert earphones for high-frequency bedside ototoxicity monitoring
Ototoxic hearing loss is usually detected earliest through monitoring of the highest audible frequencies in individuals administered ototoxic medications. Conducting ototoxicity monitoring may require testing patients in the hospital room. This study evaluated the use of insert earphones for obtaining reliable threshold responses at bedside.
Jane S, Gordon +4 more
openaire +2 more sources
Platinum-based compounds used for treating hematologic malignancies can lead to various side effects. One such side effect is ototoxicity, which is characterized by permanent bilateral sensorineural hearing loss or tinnitus.
Aleksandra Janowiak-Majeranowska +3 more
doaj +1 more source
Objectives: The goal of this study was to investigate the use of transient-evoked otoacoustic emissions (TEOAEs) and middle ear absorbance measurements to monitor auditory function in patients with cystic fibrosis (CF) receiving ototoxic medications ...
A. Garinis +7 more
semanticscholar +1 more source
Background: Advances in platinum-based chemotherapy have improved childhood cancer survival, but ototoxicity remains a major complication, particularly in younger children. This prospective study evaluated serial cochlear changes using TEOAE and DPOAE to
Monica Mrudubhashini Michael +6 more
doaj +1 more source
Background: A significant number of medications that are prescribed by doctors to treat cancers, tuberculosis and infections are ototoxic. Disclosure of ototoxic risks is ethical practice as patients have the right to be properly informed about and ...
Anna Wium, Berna Gerber
doaj +1 more source
Evoked otoacoustic emissions — an approach for monitoring cisplatin induced ototoxicity in children
Cisplatin chemotherapy is associated with an increased risk of ototoxic changes. The incidence of hearing loss after the 1st cisplatin-infusion session is only scarcely mentioned in the international literature. With increasing survival rates, prevention and/or early detection of ototoxicity are important for providing management options.
Stavroulaki, P +4 more
openaire +3 more sources

